Skip to main content

Lactated Ringer Solution Better Than Normal Saline for Sickle Cell Pain Crises

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 17, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Sept. 17, 2024 -- Administration of lactated Ringer (LR) solution has a small but significant improvement on sickle cell disease outcomes versus normal saline (NS) for fluid resuscitation during pain crises, according to a study published online Sept. 9 in JAMA Internal Medicine.

Augusta K. Alwang, M.D., from Boston University, and colleagues compared the effectiveness of LR solution versus NS for fluid resuscitation in patients with sickle cell disease and vaso-occlusive episodes. The analysis included data from 3,495 patient encounters where LR was administered and 52,079 where NS was administered on hospital day 1.

The researchers found that patients who received LR had more hospital-free days (HFDs) at 30 days compared with those who received NS (marginal mean difference, 0.4 days). Further, patients who received LR also had shorter hospital lengths of stay (marginal mean difference, −0.4 days) and a lower risk for 30-day readmission (marginal risk difference, −5.8 percent). However, differences in HFDs between the two groups were heterogenous based on fluid volume received. For patients who received <2 L, there was no difference in LR versus NS, but among those who received ≥2 L, LR was superior to NS.

"Currently, patients with sickle cell disease who are admitted to the hospital for vaso-occlusive pain episodes usually receive normal saline, and clinical decision support tools presently recommend normal saline," coauthor Nicholas Bosch, M.D., also from Boston University, said in a statement. "However, our results call these recommendations and current practice into question."

Several authors disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia

TUESDAY, April 29, 2025 -- For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital...

C-Reactive Protein Increases During Menstrual Cycle in Females With Sickle Cell Disease

TUESDAY, April 15, 2025 -- For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicular phase of the menstrual cycle...

No Evidence Found Linking Sickle Cell Trait With Unexplained Sudden Death

MONDAY, Feb. 3, 2025 -- There is no evidence to support physical exertion without rhabdomyolysis or heat injury causing sudden death in individuals with sickle cell trait (SCT)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.